Research Notes

Stay informed with the most recent market and company research insights.

A man sitting at a table with a glass of orange juice.

Research Notes

Beat vs guidance sees positive trading across SEQ

Wagners
3:27pm
February 26, 2025
A great result with operating EBIT of $20.3m beating the mid-point of guidance ($16m-$18m) by c.20% and 22% above our forecasts. Current operating conditions are forecast (by the company) to persist through 2H25, albeit with cement volumes to be slightly softer in 2H – resulting in a 1H skew to FY25 earnings. Strong operating conditions have seen debt reduce further. Looking beyond FY25, the company remains focused on expanding its South-East Queensland Concrete Plant network, a key driver for cement pull-through and margin improvement (across both cement and concrete). With WGN trading on c.14x FY26F PER and cause for optimism around the outlook for demand in South-East Queensland (SEQ), we retain our Add rating, upgrading our target price to $2.00/sh (previously $1.50/sh).

Looking to a stronger 2H

ImpediMed
3:27pm
February 26, 2025
IPD posted its 1H25 results where the net loss was higher than our forecast reflecting higher amortisation charges and administration costs being partially offset by FX gains. IPD has executed a growth funding facility providing access to up to US$15m in loans. This has taken the funding question off the table with the cost base under control and quarterly cash burn expected to be ~A$3.5m. The key catalysts to focus on include; securing orders (currently 523 units in US) from a pipeline of over 600 potential opportunities and increasing the reimbursement coverage (currently at 75% of US). We have adjusted our forecasts to reflect higher amortisation and interest charges. Our price target is slightly lower at A$0.16 (was A$0.17). Speculative buy.

Strong signs continue for growth

Microba Life Sciences
3:27pm
February 26, 2025
No major surprises in the result with MAP releasing 1H25 results which were broadly in line with our revenue and net loss forecasts. Overall, the business appears to be performing in line with expectations, with strong prescriber growth and referral rates continuing to read-through well for growth into the balance of FY25 and beyond. Our target price upgrades marginally to A$0.34 (from A$.033) and we continue to see significant upside here as the testing and services deliver scale, and the therapeutics continues to de-risk. Speculative Buy recommendation retained.

Metallurgical Face Lift Boosts Gonneville

Chalice Mining
3:27pm
February 26, 2025
Recent metallurgical results demonstrate a viable path forward using conventional processing, omitting the hydrometallurgical circuit from the flowsheet. This change enables cost savings of A$1.6 billion while reducing project risk. We upgrade our rating from Hold to Speculative Buy, with a price target of A$2.80ps. This revision is a function of CHN's share price. Broadly, we view CHN as offering option value on PGE prices, with our target price increasing by A$1.20 per share for every +US$200/oz change in Palladium. Coverage of CHN moves to Ross Bennett with this note.

It’s still tough out there

Tourism Holdings Rentals Limited
3:27pm
February 25, 2025
1H25 result was weak but was stronger than our forecast. Rentals posted a solid result while Vehicle Sales and margins were down materially. The 1H is northern hemisphere weighted and North America and UK/Ireland produced weak results. Unsurprisingly, given the difficult vehicle sales market, there is risk to THL achieving its FY25 target for NPAT growth. We have revised our forecasts. THL’s valuation metrics are undemanding. We recognise THL has material leverage to an improved economic cycle, however given earnings uncertainty remains, it is a capital-intensive business which is debt funded and lacking share price catalysts, we maintain a Hold rating.

IB&RS challenges weigh, margins to drive 2H uplift

Johns Lyng Group
3:27pm
February 25, 2025
JLG’s 1H25 result was much softer than anticipated, with Underlying NPAT of $22.6m down -33% yoy and ~30% below MorgF of $32.9m. This was primarily driven by a step down in organic revenue growth (-16.3% yoy) in JLG’s Core AUS Insurance & restoration business in addition to its US business (-10% yoy). FY25 EBITDA guidance was cut by -5% to $126.5m which implies 2H improvement in BAU earnings (58% 2H25 skew). We trim our EPS forecast by ~23% in FY25-FY27F and move to a Hold rating with a revised price target of $2.70ps.

Third consecutive result pleasing the market

Woodside Energy
3:27pm
February 25, 2025
Another solid result and positive guidance set by WDS, with a healthy dividend beat an added bonus. We expect the bears to keep moving the ‘goal posts’ until major Louisiana LNG milestones start to land (namely equity selldown(s), which don’t sound far away). We maintain our ADD rating with a net increase in target price to A$30.25 (was A$30.00), with WDS offering compelling medium-term value given an apparent unsustainable discount that has emerged over the last 12 months.

Tracking steadily upwards

Dalrymple Bay Infrastructure
3:27pm
February 25, 2025
DBI produced a largely predictable result, albeit with marginally stronger revenue and better cost management than expected. 1H25 DPS guidance was upgraded. 12 month target price lifted to $4.13. ADD retained. At current prices, 12 month forecast TSR = c.16% and 5 yr IRR = c.10% pa.

Time to turn this thing around

Domino's Pizza
3:27pm
February 25, 2025
With the 1H25 result pre-released earlier this month, there were few surprises on the key numbers. However, new information provided today around franchisee profitability, regional breakdown and 2H25 trading was more negative vs positive. As expected, SSS growth for the first 7 weeks of 2H25 softened vs the first 5 weeks due to the timing of Chinese New Year with both ANZ (still has a tough comp and NZ is weak) and Europe likely remaining sluggish in the 2H. DMP is making positive steps in the right direction with FY26 likely to be a key transition period as it executes on its turnaround strategy to improve unit economics and reignite organic growth. HOLD maintained.

Kiwi Kick to 1H25 result

Solvar
3:27pm
February 25, 2025
SVR’s 1H25 result was ahead of our expectations. Interest income of A$108.6m (decline -3.1% on pcp) was achieved on a gross loan book of ~A$930.4m. Solid underlying 1H25 cost across the group and normalising Bad Debts in NZ as the book continued to wind down, saw the NZ business contribute ~$2.6m to the groups Normalised NPAT of $18.5m during the half (which came in ahead of MorgF $16.9m). Based on SVRs reiterated guidance we make no material changes to our forecasts. Overall, this sees our DCF-based price target modestly increase to $1.55 (prev. $1.45). We retain our Add rating.

News & Insights

Michael Knox outlines the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and his own analysis for Australia.

Today, I’m presenting the first page of my updated presentation, which focuses on GDP growth and inflation expectations for major economies. Before diving into that, I want to clarify a point about U.S. trade negotiations that has confused some media outlets.

In the previous Trump Administration ,there was single trade negotiator, Robert Lighthizer, held a cabinet position with the rank of Ambassador. This time, to expedite negotiations and give them more weight, Trump has appointed two additional cabinet-level officials to handle trade talks with different regions. For Asian economies, Scott Bessent and Ambassador Jamison Greer, who succeeded Lighthizer and previously served on the White House staff, are managing negotiations, including those with China. For Europe, Howard Lutnick, the Commerce Secretary, and Ambassador Greer are negotiating with the European Trade Representative. When the EU representative visits Washington, D.C., they meet with Lutnick and Greer, while Chinese or Japanese representatives engage with Bessent and Greer.

In my presentation today, I’m outlining the economic outlook for growth and inflation in the U.S., the Euro area, China, India, and Australia, drawing data from the International Monetary Fund, the Congressional Budget Office, European sources, and my own analysis for Australia.

For the U.S., the best-case scenario is a soft landing, with growth slowing but remaining positive at 1.3% this year and rising to 1.7% next year. This slowdown allows the Federal Reserve to continue cutting interest rates, leading to a decline in the U.S. dollar. This in turn ,triggers a recovery in commodity prices. These prices have stabilized and are now trending upward, with an expected acceleration as the dollar weakens.

U.S. headline inflation is projected to be just below 3% next year, with higher figures this year driven by tariff effects.



Global Economic Perspective

In the Euro area, growth is accelerating slightly, from just under 1% this year to 1.2% next year, with inflation expected to hit the 2% target this year and dip to 1.9% next year.

China’s GDP growth is forecast  at 4% for both this year and next, a step down from previous 5% rates, reflecting a significant slump in domestic demand and very low inflation  Chinese Inflation is only  :   0.2% last year, 0.4% this year, and 0.9% next year.  Despite a massive fiscal push, with a budget deficit around 8% of GDP, China’s debt-to-GDP ratio is rising faster than the U.S.. Yet this is  yielding more modest  domestic growth.

India, on the other hand, continues to outperform, with 6.5% GDP growth last year, 6.2% this year, and  6.3%  next year, surpassing earlier projections.

Read more
In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia.

Positive earnings surprise

In our International Reporting Season Review, we provide an overview of the March 2025 quarterly results season for companies in the Americas, Europe and Asia. For all the volatility in markets caused by US trade policy, the results were positive. For all the 187 high profile and blue-chip companies in our International Watchlist, the median EPS beat vs consensus was 3.2%, nearly twice that recorded in the December quarter (1.8%). 37% of companies exceeded consensus EPS expectations by more than 5% and only 9% missed by more than 5%. Communication Services was the most positive sector, led by Magnificent 7 companies Alphabet and Meta Platforms. The median EPS beat in that sector was 13%. Consumer Discretionary was the biggest disappointment (though only a mild one) with EPS falling 0.6% short of analyst estimates on a median basis.

Alphabet and Meta among the best performers

Across our Watchlist, some of the best performing stocks in terms of EPS beats were Alphabet, Boeing, Uniqlo-owner Fast Retailing, Meta Platforms, Newmont and The Walt Disney Company. Notable misses came from insurance broker Aon, BP, PepsiCo, Starbucks, Tesla and UnitedHealth. The latter saw by far the worst share price performance over reporting season, its earnings weakness compounded by the resignation of its CEO and the launch of a fraud investigation by the Department of Justice. British luxury fashion label Burberry had the best performing share price as it gains traction in its turnaround plan.

Tariffs were the main talking point (of course)

The timing of President Trump’s ‘Liberation Day’ on 2 April, just before the March quarter results started rolling in, guaranteed that US tariffs would be the main talking point throughout reporting season. Most companies took the line that higher tariffs presented a material risk to global growth and inflation. The rapidly shifting sands of US trade policy mean the impact of tariffs is highly uncertain. This didn’t stop many companies from trying to estimate the impact on their profits. This ranged from the very precise ($850m said RTX) to the extremely vague (‘a few hundred million dollars’ hazarded Abbott Laboratories). The rehabilitation of AI as a systemic driver of long-term value was a key theme of reporting season, with many companies reporting what Palantir Technologies described as an ‘unstoppable whirlwind of demand’ and others indicating an increase in planned AI investment. The deterioration in consumer confidence was another key talking point, though most companies could only express concern about a possible future softening in demand rather than any actual evidence of a hit to sales.

Our International Focus List continues to outperform

In this report, we also report on the performance of the Morgans International Focus List, which is now up 25.3% since inception last year, outperforming the benchmark S&P 500 by 20.4%.


Morgans clients receive exclusive insights such as access to our latest International Reporting Season article.

Contact us today to begin your journey with Morgans.

      
Contact us
      
      
Find an adviser
      
Read more
The U.S. and China, through negotiations led by the Chinese Deputy Premier and U.S. Treasury Secretary Scott Bessent, agreed to a 90-day tariff reduction from over 125% to 30% and 10% respectively

US and Chinese actions had led to an unintended embargo of trade between the world’s two largest economies.

In recent days there has been discussion of the temporary “cease fire” in the tariff war between the US and China.

The situation was that both countries had levied tariffs on each other more than 125%. This had led to a mutual embargo of trade between the two world is two largest economies. Then as a result of negotiation between the Deputy Premier of China and US Treasury Secretary Scott Bessent both China and the US agreed to a 90 day pause in “hostilities” where both sides agreed to reduce the US tariff on the China to 30 percent and the Chinese tariff on the US to 10%.

Some suggested that this meant that “China had won” others suggested that the “US had won.” To us this really suggests that both parties were playing in a different game. The was a game in which both sides had won.

To understand why this is the case we must understand a little of the theory of this type of competition. Economists usually use discuss competition in terms of markets where millions of people are involved. In such a case we find a solution by finding the intersection of supply and demand which model the exchange between vast numbers of people.

But here we are ware talking of a competition where only two parties are involved.

When exceedingly small numbers like this are involved, we find the solution to the competition by what is called “Game Theory.”

In this game there are only two players. One is called China, and the other is called the US. Game theory teaches us that are there three different types of games. The first is a zero-sum game. In this game there two sides are competing over a fixed amount of product. Again, this is called " A zero sum game “. Either one party gets a bigger share of the total sum at stake and the other side gets less. This zero-sum game is how most of the Media views the competition between the US and China.

A second form is a decreasing sum game. An example of this is a war. Some of the total amount that is fought over is destroyed in the process. Usually both sides will wind up worse than when they started.

Then there is a third form. This form is called an ‘increasing sum game.’ This is where both sides cooperate so that the total sum in the game grows because of this cooperation. We think that what happened in the US and China negotiation was an increasing sum game.

As Scott Bessent said at the Saudi Investment Forum in Riyadh soon after the agreement was signed, “both sides came with a clear agenda with shared interests and great mutual respect.”

He said, “after the weekend, we now have a mechanism to avoid escalation like we had before. We both agreed to bring the tariff levels down by 115% which I think is very productive because where we were with 145% and 125% was an unintended embargo. That is not healthy for the two largest economies in the world.”

He went on, “when President Trump began the tariff program, we had a plan, we had a process. What we did not have with the Chinese was a mechanism. The Vice Premier and I now call this the ‘Geneva mechanism’”.

Both sides cooperated to make both sides better off. Bessent added “what we do not want, and both sides agreed, is a generalised decoupling between the two largest economies in the world. What we want is the US to decouple in strategic industries, medicine, semiconductors, other strategic areas. As to other countries; we have had very productive discussions with Japan, South Korea, Indonesia, Taiwan, Thailand. Europe may have collective action problems with the French wanting one thing and the Italians wanting a different thing. but I am confident that with Europe, we will arrive at a satisfactory conclusion.

We have a very good framework. I think we can proceed from here.”

What we think we can see here is that the United States and China have cooperated to both become better off. This is what we call an increasing sum game.

They will continue their negotiation using that approach. This will do much to allay the concerns that so many had about the effect of these new tariffs.

Read more